Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Leukemia|January 9, 2015
Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late eventM Jawhar, J Schwaab, S Schnittger, et al.
Annals of Hematology|May 25, 2004
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemiaW K Hofmann, G Heil, C Zander, et al.
Leukemia|October 15, 2015
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosisM Jawhar, J Schwaab, S Schnittger, et al.
Oncogene|April 29, 2009
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndromeS Boehrer, L Adès, N Tajeddine, et al.
Leukemia|November 12, 2016
Molecular alterations in bone marrow mesenchymal stromal cells derived from acute myeloid leukemia patientsE K von der Heide, M Neumann, S Vosberg, et al.
Scientific Reports|July 2, 2017
Diagnostic Performance of Contrast Enhanced Pulmonary Computed Tomography Angiography for the Detection of Angioinvasive Pulmonary Aspergillosis in Immunocompromised PatientsC Henzler, T Henzler, D Buchheidt, et al.
Annals of Hematology|November 9, 2002
Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemiaW K Hofmann, G Seipelt, S Langenhan, et al.
Mycoses|October 27, 2015
Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samplesT Boch, M Reinwald, P Postina, et al.
Journal of Clinical Microbiology|October 11, 2013
Aspergillus PCR-based investigation of fresh tissue and effusion samples in patients with suspected invasive Aspergillosis enhances diagnostic capabilitiesM Reinwald, B Spiess, W J Heinz, et al.
ESMO Open|November 26, 2025
Clinical benefit of additional whole-exome sequencing over panel sequencing in an all-comer real-world molecular tumor boardE Krieghoff-Henning, T Michaeli, T Boch, et al.
Pageof 7